| 12116368 |
Pyrrolo[2,3-d]pyrimidine tosylate salt, crystalline form thereof and manufacturing process and intermediates thereto |
Brian Matthew Samas, Yong Tao, Douglas James Critcher, David Sydney Bernard Daniels, Kevin Paul Girard +1 more |
2024-10-15 |
$352,920,000 |
| 11299500 |
Crystalline form of lorlatinib free base hydrate |
Paul Bowles |
2022-04-12 |
$2,343,905,000 |
| 9056831 |
Process for forming amorphous atorvastatin |
Antone John deBettencourt, III, Evgenyi Shalaev, George J. Quallich, Carl Bernard Ziegler |
2015-06-16 |
$141,497,000 |
| 8258315 |
Process for forming amorphous atorvastatin |
Antone John deBettencourt, III, Evgenyi Shalaev, George J. Quallich, Carl Bernard Ziegler |
2012-09-04 |
$308,802,000 |
| 8026376 |
Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoicacid calcium salt (2:1) |
Joseph Francis Krzyzaniak, George Laurence, Aeri Park, Kevin Quackenbush, Marie Louise Reynolds +1 more |
2011-09-27 |
$535,112,000 |
| 7285686 |
Process for the preparation of 1,3-substituted indenes |
Robert Eugene Handfield, Jr., Timothy J. Watson, Phillip J. Johnson |
2007-10-23 |
$674,929,000 |
| 7265119 |
Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
David E. Bogle, Glenn R. Williams |
2007-09-04 |
$133,000,000 |
| 6890927 |
Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
David E. Bogle, Glenn R. Williams |
2005-05-10 |
$387,714,000 |
| 6787549 |
Citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
Phillip J. Johnson, Glenn R. Williams, Lewin T. Wint |
2004-09-07 |
$150,240,000 |
| 6696574 |
Processes and intermediates for preparing glycogen phosphorylase inhibitors |
Mark T. Barrila, Frank R. Busch, Michel A. Couturier, Susan Orrill, Derek Tickner +2 more |
2004-02-24 |
$241,090,000 |
| 6683106 |
N-(indole-2-carbonyl)-b-alaninamide crystal forms |
Douglas J. M. Allen, Frank R. Busch, Joseph Francis Krzyzaniak, Zheng Li, Susan Orrill +2 more |
2004-01-27 |
$315,255,000 |
| 6673929 |
Process for preparing growth hormone secretagogues |
Frank R. Busch, Charles K. Chiu, Clifford N. Meltz, Ronald J. Post |
2004-01-06 |
$383,165,000 |
| 6573383 |
Preparation of anhydrous CETP inhibitor |
— |
2003-06-03 |
$850,859,000 |
| 6541634 |
Process for preparing growth hormone secretagogues |
Frank R. Busch, Charles K. Chiu, Clifford N. Meltz, Ronald J. Post |
2003-04-01 |
$432,043,000 |
| 6387925 |
Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
George J. Quallich, Lewin T. Wint, Stephen S. Massett |
2002-05-14 |
$130,007,000 |
| 6359137 |
Process for preparing trovafloxacin acid salts |
Timothy Norris, Keith M. DeVries |
2002-03-19 |
$869,707,000 |
| 6013808 |
Method of purifying carbazole ester precursors of 6-chloro-.alpha.-methyl-carbazole-2-acetic acid |
Philip D. Hammen, John Tucker, Keith M. DeVries, Diane M. Rescek |
2000-01-11 |
$593,888,000 |
| 5929240 |
Process and intermediates for preparing naphthyridonecarboxylic acid salts |
Tamim F. Braish, Darrell E. Fox, Timothy Norris |
1999-07-27 |
$959,191,000 |
